Clinical outcomes in stage III non-small cell lung cancer patients treated with durvalumab after sequential or concurrent platinum-based chemoradiotherapy – single institute experience
Authors
Martina Vrankar
Institute of Oncology Ljubljana, Department of Radiotherapy, Ljubljana, Slovenia
University of Ljubljana, Faculty of Medicine, Ljubljana, Slovenia
Karmen Stanic
Institute of Oncology Ljubljana, Department of Radiotherapy, Ljubljana, Slovenia
University of Ljubljana, Faculty of Medicine, Ljubljana, Slovenia
Stasa Jelercic
Institute of Oncology Ljubljana, Department of Radiotherapy, Ljubljana, Slovenia
Eva Ciric
Institute of Oncology Ljubljana, Department of Radiotherapy, Ljubljana, Slovenia
Ana Lina Vodusek
Institute of Oncology Ljubljana, Department of Radiotherapy, Ljubljana, Slovenia
Jasna But-Hadzic
Institute of Oncology Ljubljana, Department of Radiotherapy, Ljubljana, Slovenia
University of Ljubljana, Faculty of Medicine, Ljubljana, Slovenia
Language: English
Page range: 482 - 490
Submitted on: Aug 19, 2021
Accepted on: Oct 7, 2021
Published on: Nov 19, 2021
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Related subjects:
© 2021 Martina Vrankar, Karmen Stanic, Stasa Jelercic, Eva Ciric, Ana Lina Vodusek, Jasna But-Hadzic, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.